213 related articles for article (PubMed ID: 23633584)
21. The effect of a proline residue on the rate of growth and the space group of alpha-spectrin SH3-domain crystals.
Cámara-Artigas A; Andújar-Sánchez M; Ortiz-Salmerón E; Cuadri C; Casares S
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1247-52. PubMed ID: 19966410
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
23. Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.
Tibaldi E; Venerando A; Zonta F; Bidoia C; Magrin E; Marin O; Toninello A; Bordin L; Martini V; Pagano MA; Brunati AM
Biochem J; 2011 Nov; 439(3):505-16. PubMed ID: 21732913
[TBL] [Abstract][Full Text] [Related]
24. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
25. Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation.
Martín-García JM; Luque I; Mateo PL; Ruiz-Sanz J; Cámara-Artigas A
FEBS Lett; 2007 May; 581(9):1701-6. PubMed ID: 17418139
[TBL] [Abstract][Full Text] [Related]
26. Understanding the polymorphic behaviour of a mutant of the α-spectrin SH3 domain by means of two 1.1 Å resolution structures.
Cámara-Artigas A; Gavira JA; Casares S; Garcia-Ruiz JM; Conejero-Lara F; Allen JP; Martinez JC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):189-96. PubMed ID: 21358049
[TBL] [Abstract][Full Text] [Related]
27. Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src.
Shen Z; Batzer A; Koehler JA; Polakis P; Schlessinger J; Lydon NB; Moran MF
Oncogene; 1999 Aug; 18(33):4647-53. PubMed ID: 10467411
[TBL] [Abstract][Full Text] [Related]
28. The impact of either 4-R-hydroxyproline or 4-R-fluoroproline on the conformation and SH3m-cort binding of HPK1 proline-rich peptide.
Borgogno A; Ruzza P
Amino Acids; 2013 Feb; 44(2):607-14. PubMed ID: 22976002
[TBL] [Abstract][Full Text] [Related]
29. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
30. The promiscuous binding of the Fyn SH3 domain to a peptide from the NS5A protein.
Martin-Garcia JM; Luque I; Ruiz-Sanz J; Camara-Artigas A
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):1030-40. PubMed ID: 22868769
[TBL] [Abstract][Full Text] [Related]
31. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
[TBL] [Abstract][Full Text] [Related]
32. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
Chan DC; Bedford MT; Leder P
EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
[TBL] [Abstract][Full Text] [Related]
33. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
[TBL] [Abstract][Full Text] [Related]
35. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
37. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
Lerner EC; Smithgall TE
Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
[TBL] [Abstract][Full Text] [Related]
38. Ligand-induced strain in hydrogen bonds of the c-Src SH3 domain detected by NMR.
Cordier F; Wang C; Grzesiek S; Nicholson LK
J Mol Biol; 2000 Dec; 304(4):497-505. PubMed ID: 11099375
[TBL] [Abstract][Full Text] [Related]
39. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
40. Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain.
Karatan E; Merguerian M; Han Z; Scholle MD; Koide S; Kay BK
Chem Biol; 2004 Jun; 11(6):835-44. PubMed ID: 15217616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
